Efficacy of pulmicort suspension plus salbutamol and ipratropium bromide for management of acute asthma exacerbation in children: a comparative study.
- Author:
Zhuang-gui CHEN
1
;
Ming LI
;
Hong CHEN
;
Yan-feng CHEN
;
Fen-hua CHEN
;
Jing-zhi JI
Author Information
- Publication Type:Journal Article
- MeSH: Acute Disease; Adolescent; Aerosols; Albuterol; administration & dosage; therapeutic use; Asthma; drug therapy; Bronchodilator Agents; administration & dosage; therapeutic use; Budesonide; administration & dosage; therapeutic use; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Ipratropium; administration & dosage; therapeutic use; Male; Treatment Outcome
- From: Journal of Southern Medical University 2008;28(3):470-472
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo evaluate the efficacy of 3 commonly used protocols for management of acute exacerbation of asthma in children.
METHODSTotally 113 asthmatic children were randomized into 3 groups. In group A (53 cases), the children were treated with inhalation of nebulized budesonide suspension plus salbutamol and ipratropium bromide twice daily for 5 days; in group B (41 cases), budesonide plus salbutamol and ipratropium aerosol was administered, and in group C (29 cases), dexathmisone plus aminophylline injection was given once daily for 5 days. All the children received basic treatment with fluid infusion, antibiotics or/and anti-virus medications.
RESULTSThe children in both groups A and C showed effectively controlled asthma attack, with significant differences in the therapeutic effects (P>0.05). In contrast, only a few children showed improvement in group B, suggesting the ineffectiveness of the treatment.
CONCLUSIONNebulized medicine is one of the best means for management of acute asthma exacerbation in children, and inhalation of budesonide suspension plus salbutamol and ipratropium bromide can effectively relieve the asthmatic symptoms in these children with good compliance and convenient administration.
